SM

Samras Mayimi

Active Director Additional Director DIN 07202187
DIN 07202187 First appointment Jul 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 9 active board seats
Past companies 2 historical roles
Total affiliations 11 Since Jul 2017
Shareholding value •••• Premium profile

About Samras Mayimi

Data last updated:

Samras Mayimi is an Additional Director at Cryotech Pharma Private Limited (since 2021), Director at Nrgcorp Solar Private Limited (since 2025) and Director at Exeed Varsity Private Limited (since 2025), and holds 6 more current directorships. The companies operate in Pharma, Education and Cleantech. The largest current company by reported revenue is Cryotech Pharma Private Limited at ₹4.7 Lakh (FY 2023). Earlier, Samras Mayimi was a Director at Plasmatron Global Private Limited (from 2024) and Director at Eurasian Business Services Private Limited (from 2023).

DIN 07202187
Primary Designation Additional Director
Industry Pharma
First Appointment 28 Jul 2017
Oldest Company Age 9 yrs
Largest company Cryotech Pharma Private Limited · ₹4.7 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cryotech Pharma Private Limited U24299KL2020PTC063179
Additional Director22 Jun 20212020₹4.7 Lakh (FY 2023)Active
Nrgcorp Solar Private Limited U35105KA2025PTC212243
Director11 Dec 20252025Active
Exeed Varsity Private Limited U85500KL2025PTC096832
Director02 Sep 20252025Active
Director02 Sep 20252025Active
Director27 Mar 20252025Active
Frosty Food India Private Limited U47219KL2025PTC091288
Director04 Jan 20252025Active
Nrg Corporations Private Limited U66190TN2023PTC163873
Director22 Sep 20232023Active
Managing Director12 Nov 20212019Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Plasmatron Global Private Limited U70100DL2024PTC436003
Director28 Aug 20242024Strike Off
Director29 Dec 20232023Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cryotech Pharma Private Limited
Restart Energy Automobile Private Limited
Exeed Varsity Private Limited
Innature Holidays Llp
Premium access

Shareholding and investment profile for Samras Mayimi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Samras Mayimi

Samras Mayimi currently holds 9 directorships: Cryotech Pharma Private Limited (Additional Director, since 22 Jun 2021, revenue ₹4.7 Lakh (FY 2023)); Nrgcorp Solar Private Limited (Director, since 11 Dec 2025); Exeed Varsity Private Limited (Director, since 02 Sep 2025); Eaton Institute Of Management & Training Private Limited (Director, since 02 Sep 2025); Plasmatron Global Energy Solutions Private Limited (Director, since 27 Mar 2025); and 4 more.

Samras Mayimi was first appointed on 28 Jul 2017 as Designated Partner at Innature Holidays Llp. The most recent appointment on record is 11 Dec 2025 at Nrgcorp Solar Private Limited.

Samras Mayimi held 2 earlier board appointments: Plasmatron Global Private Limited (Director, from 28 Aug 2024); Eurasian Business Services Private Limited (Director, from 29 Dec 2023).

The current boards of Samras Mayimi's companies include Jaya Prakash Nair (Cryotech Pharma Private Limited), Lalu Joseph (Cryotech Pharma Private Limited), Reghunathan Pillai Dasappan Pillai (Cryotech Pharma Private Limited), Salim Shahul Hameed (Cryotech Pharma Private Limited), Sergei Afanasev (Cryotech Pharma Private Limited), Mashrookhu Abdul Gafoor Ali (Exeed Varsity Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available